BEAM Annual Shareholders Equity
$981.33 M
+$247.85 M+33.79%
31 December 2023
Summary:
As of January 23, 2025, BEAM annual stockholders equity is $981.33 million, with the most recent change of +$247.85 million (+33.79%) on December 31, 2023. During the last 3 years, it has risen by +$735.77 million (+299.63%). BEAM annual shareholders equity is now at all-time high.BEAM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BEAM Quarterly Shareholders Equity
$791.32 M
-$62.78 M-7.35%
30 September 2024
Summary:
As of January 23, 2025, BEAM quarterly stockholders equity is $791.32 million, with the most recent change of -$62.78 million (-7.35%) on September 30, 2024. Over the past year, it has dropped by -$62.78 million (-7.35%). BEAM quarterly shareholders equity is now -19.36% below its all-time high of $981.33 million, reached on December 31, 2023.BEAM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BEAM Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.8% | -7.3% |
| 3 y3 years | +299.6% | -7.3% |
| 5 y5 years | +632.2% | +524.5% |
BEAM Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +33.8% | -19.4% | +10.8% |
| 5 y | 5-year | at high | +872.1% | -19.4% | +683.9% |
| alltime | all time | at high | >+9999.0% | -19.4% | +683.9% |
Beam Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $791.32 M(-7.4%) |
| June 2024 | - | $854.09 M(-6.5%) |
| Mar 2024 | - | $913.49 M(-6.9%) |
| Dec 2023 | $981.33 M(+33.8%) | $981.33 M(+26.0%) |
| Sept 2023 | - | $778.94 M(-4.0%) |
| June 2023 | - | $811.64 M(+6.6%) |
| Mar 2023 | - | $761.51 M(+3.8%) |
| Dec 2022 | $733.47 M(-11.3%) | $733.47 M(+2.7%) |
| Sept 2022 | - | $714.48 M(-10.7%) |
| June 2022 | - | $800.16 M(-3.5%) |
| Mar 2022 | - | $829.07 M(+0.3%) |
| Dec 2021 | $826.74 M | $826.74 M(-3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $853.81 M(+55.6%) |
| June 2021 | - | $548.55 M(+29.9%) |
| Mar 2021 | - | $422.43 M(+72.0%) |
| Dec 2020 | $245.56 M(+143.3%) | $245.56 M(+22.7%) |
| Sept 2020 | - | $200.07 M(-13.3%) |
| June 2020 | - | $230.82 M(-11.7%) |
| Mar 2020 | - | $261.39 M(+158.9%) |
| Dec 2019 | $100.94 M(-24.7%) | $100.94 M(-20.3%) |
| Sept 2019 | - | $126.72 M(-11.8%) |
| June 2019 | - | $143.65 M(+7.2%) |
| Dec 2018 | $134.03 M(-3304.1%) | $134.03 M |
| Dec 2017 | -$4.18 M | - |
FAQ
- What is Beam Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Beam Therapeutics?
- What is Beam Therapeutics annual shareholders equity year-on-year change?
- What is Beam Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Beam Therapeutics?
- What is Beam Therapeutics quarterly shareholders equity year-on-year change?
What is Beam Therapeutics annual stockholders equity?
The current annual shareholders equity of BEAM is $981.33 M
What is the all time high annual shareholders equity for Beam Therapeutics?
Beam Therapeutics all-time high annual stockholders equity is $981.33 M
What is Beam Therapeutics annual shareholders equity year-on-year change?
Over the past year, BEAM annual stockholders equity has changed by +$247.85 M (+33.79%)
What is Beam Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of BEAM is $791.32 M
What is the all time high quarterly shareholders equity for Beam Therapeutics?
Beam Therapeutics all-time high quarterly stockholders equity is $981.33 M
What is Beam Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, BEAM quarterly stockholders equity has changed by -$62.78 M (-7.35%)